Global Longlife Hospital Reports Updated Stake Sale by Dhruv Sureshkumar Jani
Global Longlife Hospital & Research received a substantial acquisition disclosure from Dhruv Sureshkumar Jani regarding the sale of 1,00,000 equity shares between December 10-11, 2025. The transaction reduced Jani's stake from 10,00,000 shares (9.52%) to 9,00,000 shares (8.57%), while the company's total equity capital remains unchanged at ₹10.50 crores with 1,05,00,000 shares.

*this image is generated using AI for illustrative purposes only.
Global Longlife Hospital & Research has received an updated substantial acquisition disclosure from Dhruv Sureshkumar Jani regarding the sale of equity shares under SEBI regulations. The latest transaction represents a significant change in the company's shareholding pattern, with regulatory filings submitted to BSE Limited on December 11, 2025.
Updated Transaction Details
Dhruv Sureshkumar Jani executed the sale of 1,00,000 equity shares of Global Longlife Hospital and Research Limited between December 10, 2025 and December 11, 2025. The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, indicating the materiality of this transaction.
| Transaction Parameter | Details |
|---|---|
| Shares Sold | 1,00,000 equity shares |
| Transaction Period | December 10 - December 11, 2025 |
| Seller | Dhruv Sureshkumar Jani |
| Regulatory Framework | SEBI Regulation 29(2) |
| Mode of Sale | Open Market |
Shareholding Changes
The latest transaction resulted in a notable reduction in Jani's stake in the company. His shareholding decreased from 10,00,000 shares to 9,00,000 shares, representing a change from 9.52% to 8.57% of the company's total voting capital based on the recent sale.
| Shareholding Metric | Before Sale | After Sale | Change |
|---|---|---|---|
| Number of Shares | 10,00,000 | 9,00,000 | -1,00,000 |
| Percentage Holding | 9.52% | 8.57% | -0.95% |
| Voting Rights | 9.52% | 8.57% | -0.95% |
Company Capital Structure
Global Longlife Hospital and Research Limited maintains its equity share capital structure unchanged following this transaction. The company's total equity share capital remains at ₹10.50 crores, divided into 1,05,00,000 equity shares of ₹10.00 each.
| Capital Structure | Details |
|---|---|
| Total Equity Capital | ₹10.50 crores |
| Number of Shares | 1,05,00,000 |
| Face Value per Share | ₹10.00 |
| BSE Scrip Code | 543520 |
| ISIN | INE0J2K01014 |
Regulatory Compliance
The disclosure demonstrates compliance with SEBI's substantial acquisition regulations, which require mandatory reporting when shareholding changes cross specified thresholds. Jani, operating from 25 Divine Bunglows, Science City Road, Sola, Ahmedabad, Gujarat, submitted the required documentation to both BSE Limited and the company, ensuring full regulatory transparency.
The transaction maintains the company's existing capital structure while reflecting changes in its ownership pattern, with no dilution of share capital or voting rights reported in the filing.
Historical Stock Returns for Global Longlife Hospital & Research
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +7.86% | +41.30% | -9.43% | -18.45% | -30.94% | -83.67% |



























